Latest trends, growth, size, share, forecast and outlook in market research industry. Syndicated research reports, customized research reports, and consulting services.
The Italy dropshipping market size is expected to reach USD 5.82 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 18.1% from 2021 to 2028. Although e-commerce penetration is lower than 5% in Italy, the COVID-19 pandemic in 2020 proved transformational for the online business models. Since the outbreak of coronavirus and the resultant lockdown, the uptake of online shopping has witnessed a surge. While it is early to deduce whether the pandemic will bring about a massive shift in consumer buying behavior or not, it is most likely expected to result in changing shopping habits among consumers.
A shift in consumer preference for online shopping amidst the pandemic will bring about several changes to the logistic and e-commerce sector in the country. Although the grocery and provision sector has been at the forefront in online shopping through 2020, we expect this will create a shift in consumer buying patterns, with habits gradually expected to change from brick-and-mortar to online shopping. These changing patterns will create considerable opportunities for online marketplaces that offer various product categories ranging from apparel to electronics.
E-commerce growth has resulted in investments in the Italian logistics sector. In 2019, these investments exceeded USD 1 billion, an uptick over the last couple of years. The growth in online commerce came on the back of investments in the logistics sector in 2017, mainly because of the Logicor deal
Growing smartphone penetration and access to the internet have emerged as the key factors driving the market growth. In Italy, the smartphone penetration rate is over 40%, and it is estimated that, by the end of 2025, more than 70% population in the country is estimated to use a smartphone
Several companies, such as Shopify and Magento, Inc., to name a few, are developing mobile applications for sellers to manage multiple suppliers across the dropshipping business
Even the e-commerce software companies are focused on designing multi-vendor dropshipping mobile applications with features that allow sellers in managing orders, location tracking, addition/editing of products, viewing transaction lists and product lists, and more
Such innovations/software upgrades help companies manage their dropshipping businesses smoothly. The increasing adoption of these solutions is expected to drive the market growth
Grand View Research has segmented the Italy dropshipping market based on product:
Italy Dropshipping Product Outlook (Revenue, USD Million, 2017 - 2028)
Food
Furniture
Beauty & Personal Care
Personal Electronics and Media
Other Electronics (Home Appliances including Refrigerators, Washing Machines, Television, etc.)
Fashion
Others (Toys, Hobby, & DIY)
List of Key Players in the Italy Dropshipping Market
com
com
com
Medici in Firenze
MediaToys Srl
Oberlo
co.uk
Shopify, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
The global smart stethoscope market size is expected to reach USD 76.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. A surge in the geriatric population, high adoption of technologically advanced products, growing healthcare infrastructure, and various government initiatives are the key driving factors for the market.
The smart stethoscope is user-friendly and cost-effective equipment that assists physicians in obtaining reliable results. Based on heart rate, these stethoscopes help in the diagnosis of respiratory diseases and disorders. Until now, the traditional stethoscope has played a significant role in the department of cardiology. Though, the medical device has some disadvantages, such as poor sound quality, which is particularly noticeable in obese patients and those with a thick chest wall. Hence, there is a booming demand for advanced stethoscopes to replace the traditional version of the medical, leading to market growth.
High prevalence of cardiovascular disorders, enhanced diagnosis, are other factors driving the market. As projected by the WHO, heart disease is the leading cause of death in the U.S., causing around 647,000 deaths every year. Technological advances, as well as the continuous introduction of new and innovative products, are key drivers of business expansion. For instance, recently in July 2020, HD Medical received FDA clearance for its HD Steth that uses artificial intelligence to aid clinicians to perform an advanced cardiac assessment at point-of-care.
Auscultation of the chest is important in COVID-19 patients, particularly those with poor respiratory conditions such as serious pneumonia and respiratory dysfunction, as well as intensive cases who are anesthetized and whose breathing is supported by a ventilator. Nevertheless, proper auscultation of these patients is challenging when medical staff wears personal protective equipment and when communicating with patients is restricted. In such cases, smart stethoscopes are witnessing a major upswing in popularity and novelty.
In terms of application, the cardiovascular segment held the largest revenue share of 28.7% in 2020 owing to the increasing prevalence of heart diseases
In terms of end-use, the hospitals segment held the largest revenue share in 2020. The segment growth is majorly driven by the increasing number prevalence of cardiac and lung disorders
In Asia Pacific, the market is expected to witness the highest CAGR of 7.5% during the forecast period owing to the rising aging population and presence of huge untapped potential
Grand View Research has segmented the global smart stethoscopes market on the basis of application, end use, and region:
Smart Stethoscope Application Outlook (Revenue, USD Million, 2016 - 2028)
Cardiovascular
Neonatal
Pediatric
Fetal
Teaching
Others
Smart Stethoscope End-use Outlook (Revenue, USD Million, 2016 - 2028)
Hospitals
Clinics
Ambulatory Surgical Centers (ASCs)
Smart Stethoscope Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
US.
Canada
Europe
UK.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
MEA
South Africa
Saudi Arabia
UAE
List of Key Players of Smart Stethoscope Market
3M
Thinklabs
HD Medical, Inc.
Eko Devices, Inc.
eKuore
M3DICINE Pty Ltd.
Sonavi Labs
Steth IO
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
The global life science analytics marketsize is expected to reach USD 14.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2021 to 2028. The growing need to improve patient outcomes and reduce healthcare costs is contributing to the growing demand for life science analytical solutions. The growing demand for personalized medicine and the rising impact of social media and the internet on shaping the healthcare industry are boosting growth. Furthermore, the growing adoption of analytical solutions and the emergence of advanced analytics for the life science industry is further driving the market during the forecast period.
The ongoing Covid-19 pandemic has burdened healthcare systems across the globe and is anticipated to drive the demand for analytics in the life science industry. Technological advancements during the pandemic have enabled healthcare systems to develop solutions to overcome physical limitations of capital and labor and open up new sources of value and growth. For instance, Moderna and IBM utilized artificial intelligence, cloud computing, and blockchain solutions to support Covid-19 vaccine management.
Based on component, the services segment accounted for the largest revenue share in 2020 owing to the increasing trend of outsourcing these services since healthcare and life science companies lack resources and capabilities to deploy analytical software and services. Additionally, the services segment is expected to exhibit the fastest growth during the forecast period owing to multi-package services offered by these outsourced companies.
In 2020, the descriptive type segment accounted for the largest revenue share owing to the growing demand for descriptive and quantifiable analysis using historic data. The growing need of understanding past behavior of consumers and serviceable audience to predict future market dynamics using data mining techniques are contributing to the growth of the descriptive type segment. On the other hand, the predictive type segment is anticipated to register the fastest-growing during the forecast period owing to the increasing adoption of advanced analytics to predict possible future outcomes and aids stakeholders in designing strategies and devise appropriate tactics to sustain and improve performance.
Based on the application, the sales and marketing support segment accounted for the largest revenue share in 2020 owing to the increasing adoption of big data analytics in the sales and marketing vertical of life science companies to attain higher consumer responsiveness and gain consumer insight to enhance sales productivity. On the other hand, the research and development segment is expected to exhibit the fastest growth during the forecast period owing to the growing pipeline of pharmaceutical and medical device companies. In addition, the segment is expected to experience an increase in demand for licensing products and technologies and would eventually contribute to the growth and development of the market.
In 2020, the on-premise delivery segment accounted for the highest revenue share owing to the ease of access from remote locations with minimized costs and maintenance. On the other hand, the on-demand delivery segment is anticipated to grow fast during the forecast period owing to the increasing adoption of cloud computing solutions. In addition, increased usage of the internet and web-based services and its enhanced accessibility from the most remote locations are contributing to segment growth.
Based on end-user, pharmaceutical companies accounted for the largest revenue share in 2020 owing to the rising adoption of analytical software solutions to enhance the efficiency of clinical trials and increase drug utilization. On the other hand, the biotechnology segment is anticipated to grow fast during the forecast period owing to the increasing adoption of analytics in genome analysis and sequencing to curb expenditure. In addition, the availability of personalized data analytic solutions is increasing the growth and development of the segment.
In 2020, North America dominated the market and accounted for the largest revenue share. This can be attributed to the rise in adoption of advanced analytics, growing geriatric population and increasing prevalence of non-communicable diseases, high economic development, and presence of well-equipped infrastructure and facilities. On the other hand, Asia Pacific is expected to be the fastest-growing region during the forecast period owing to infrastructure investments, regional expansion, economic development, and low-cost and highly skilled workforce is boosting the growth of the market in Asia Pacific.
The market is anticipated to witness significant growth over the forecast period owing to the increasing adoption of analytics and the emergence of advanced analytics in the life science industry
The services component segment dominated the market in 2020, owing to the growing trend of outsourcing these services
The descriptive type segment dominated the market in 2020, owing to the growing demand for descriptive and quantifiable analysis to understand business scenarios
The sales and marketing support application segment dominated the market in 2020, owing to the increasing adoption of analytical solutions to enhance sales productivity
The on-premise delivery mode segment dominated the market in 2020 owing to the easy accessibility of these solutions from remote locations
The pharmaceutical companies segment dominated the market in 2020 owing to the growing pipeline and need of enhancing clinical trial efficiency and rising demand for personalized medicine
North America dominated the market in 2020 owing to technological advancements in well-equipped facilities
Grand View Research has segmented the global life science analytics market on the basis of component, type, application, delivery, end user, and region.
Life Science Analytics Component Outlook (Revenue, USD Million, 2016 - 2028)
Software
Services
Life Science Analytics Type Outlook (Revenue, USD Million, 2016 - 2028)
Reporting
Descriptive
Predictive
Prescriptive
Life Science Analytics Application Outlook (Revenue, USD Million, 2016 - 2028)
Research and Development
Sales and Marketing Support
Regulatory Compliance
Supply Chain Analytics
Pharmacovigilance
Life Science Analytics Delivery Outlook (Revenue, USD Million, 2016 - 2028)
On-demand
On-premise
Life Science Analytics End-user Outlook (Revenue, USD Million, 2016 - 2028)
Medical Device
Pharmaceutical
Biotechnology
Others
Life Science Analytics Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
The U.S.
Canada
Europe
UK.
Germany
Spain
France
Italy
Asia Pacific
China
Japan
India
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
UAE
List of Key Players of Life Science Analytics Market
Accenture
Cognizant
IBM
Oracle
SAS Institute, Inc.
Wipro Limited
IQVIA
Take Solutions Limited
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
North America Electric Vehicles Market Growth & Trends
The North America electric vehicles market size is expected to reach USD 147.60 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 37.2% from 2021 to 2028. Favorable initiatives to promote the adoption of electric vehicles coupled with rising crude oil prices are anticipated to drive the demand for Electric Vehicles (EVs). Electric vehicles generate power using an electric motor instead of an internal combustion engine that burns a mix of fuels and gases for power generation. The increasing advantages of electric vehicles over conventional vehicles such as zero fuel emission, better performance, and lower total cost of ownership are expected to contribute to the growing demand for electric vehicles in the coming years.
The growing preference for electric vehicles is prompting leading automotive manufacturers to launch electric vehicles. For instance, General Motors, a U.S.-based automotive company, has announced its plan to launch electric vehicles for personal use in the next few years. By 2025, the company will launch 30 EVs worldwide, and around two-third will be available in North America. The market's lucrative nature is expected to encourage more conventional vehicle manufacturers to shift into the electric vehicle space.
The outbreak of the COVID-19 pandemic has changed the overall business scenario for 2020 as well as for the next few years to come. Several industries and industry verticals have witnessed a significant setback due to the pandemic, and the automobile industry is no exception to that. The slumped business scenario has negatively impacted the production and sales of electric vehicles across North America. The electric bus sales in North America in 2020 totaled around 500 units, which was significantly lesser units recorded in 2019, registering a year-on-year decline of over 10% primarily due to the pandemic. However, with increasing government initiatives to adopt electric vehicles, the market is likely to witness significant growth over the forecast period.
In 2020, the U.S. captured around 70% of the electric vehicle demand in North America and is estimated to register a CAGR exceeding 30% from 2021 to 2028. This share is attributed to the rising demand for electric vehicles in the U.S. Moreover, new initiatives are being taken up by charging network companies, automotive manufacturers, and policymakers, and they have launched a new non-profit organization named Veloz. The new organization aims at attracting marketing, innovation, investment, and driving the regional market growth.
North America Electric Vehicles Market Report Highlights
In terms of product, the PHEV segment is estimated to register the highest CAGR of over 35% from 2021 to 2028 owing to the increasing demand for electric buses and trucks across the logistics and transportation industry
In terms of vehicle type, the PCLT segment emerged as the largest segment in 2020 and is anticipated to retain its dominance over the forecast period
Canada is projected to register the fastest CAGR exceeding 40% from 2021 to 2028 as the government in the country is focused on advancing the programs to support electric vehicle adoption
North America Electric Vehicles Market Segmentation
Grand View Research has segmented the North America electric vehicles market based on product, vehicle type, and region:
North America Electric Vehicles Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)
Battery Electric Vehicle (BEV)
Plug-In Hybrid Electric Vehicle (PHEV)
North America Electric Vehicles Type Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)
PCLT
Passenger Cars
Light Trucks
Commercial Vehicles
North America Electric Vehicles Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)
North America
US.
Canada
List of Key Players in the North America Electric Vehicles Market
BYD Company Ltd.
Daimler AG
Ford Motor Company
General Motors Company
Lucid
Mitsubishi Motors Corporation
Nissan Motor Company
Tesla
TOYOTA MOTOR CORPORATION
Volkswagen AG
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
We all have seen those advertisements that show kids jumping into candies and chocolates, only to scream in pain as their tooth starts to give them trouble. What next? Changing your toothpaste? That’s what they show us; but what happens if the problem is too severe? Well, then straight to your 2:30 appointment at the dentist. And we all have been to the dentist’s office at some point of time. Our visits may range from a regular dental checkup, to having an aching tooth removed, having out teeth whitened, or getting braces fitted. Whatever it is, dentists go a long way in keeping our teeth in good shape, no pun intended.
Dental Facilities Solve our ‘Teething’ Problems
The data from CDC certainly backs up the whatever I mentioned above regarding the importance of dentists. For example, 13.2% children between the ages of 5-19 years had untreated dental caries between 2015-2018. Furthermore, in 2019, almost 65% of adults aged 18 years or above made a visit to the dentist, while this number was even higher at 86% for children between 2-17 years. The high demand for dentists has naturally created a lot of scope in the market for dental equipment, with a number of companies having the required knowledge and expertise to operate in this space. These equipment can be categorized under radiology equipment, lasers, systems and parts, laboratory machines, hygiene maintenance devices, and others. With dentists facing higher volume of visits in recent years, the efficiency, functioning and maintenance of equipment attains prime importance.
COVID-19: Shaping the Industry Future?
The COVID-19 pandemic has had a telling impact on the global market, with governments uniformly implementing lockdowns and social distancing norms for the general population. Dental procedures have been negatively impacted, being as they are classified as non-essential procedures. Furthermore, they have been considered as one of the riskier pathways in terms of being affected by the virus, which has created major challenges for the entire industry. As such, the dental equipment market is expected to witness delayed growth in the coming years. The near future is expected to be characterized by dental establishments trying to procure new and innovative procedures and equipment that can keep away the pandemic from the patients.
Some noticeable trends seen during the coronavirus pandemic, and what they would mean for the coming years, have been tabulated below:
Aspect
COVID-19 Impact
Post-COVID Outlook
Physical Visits
The COVID-19 pandemic had a negative impact on the dental equipment market, as government-induced lockdowns and classification of dental procedures as non-essential led to a sharp drop in physical visits by patients and clients.
As governments across majority of the countries have relaxed lockdown norms due to fall in COVID-19 cases, dental clinics have slowly but surely resumed operations, which is expected to drive the industry towards positive growth in coming months.
Equipment Safety
The Journal of Contemporary Dental Practice states that dental services may be among the last to relaunch in post-pandemic relaxations since procedures are at high risk of transmission.
Even as dental procedures make a return, there is a high demand for more safer equipment and tools. It is expected that practitioners will introduce features such as decontamination processes and PPEs, which will positively impact the dental equipment industry.
How Are Dental Equipment Companies Coping?
According to PSNet, dentists have been advised to utilize dental hand-piece with anti-retraction function, high evacuation suction and rubber dams, and four-handed dentistry, as a means to minimize droplet splatter and aerosol generation.
The requirement of a number of equipment that can ensure safety for both the patient and dentist is expected to drive industry growth in the coming months. For example, A-dec has introduced a number of equipment to ensure proper sterilization at the dental facility. On similar lines, Planmeca has introduced the Planmeca Cleanic 500 air purification system specifically for dental clinics. Such equipment can be expected to become mainstay in the coming years.
What can we expect ahead?
Final Thoughts…
Notwithstanding the substantial impact of the pandemic on the dental equipment industry, it is expected that the market will bounce back in the near future, and the innovations and developments by the major market players will have a huge role to play in this regard. What’s more, in this age of digitization, it is expected that the combination of physical visits and teledentistry will keep the industry in sync with consumers. Furthermore, as medical tourism bounces back, and the geriatric population continues to expand in the coming years, we can expect the dental equipment industry to hopefully thrive in a positive environment.
Pandemic has led to a boost in demands for testing, and biosensor companies are competing with each other to develop chips that can detect the presence of the coronavirus RNA, antibodies, and antigens
COVID-19 as a Damocles sword hanging right above our heads all the time, no matter where we go, has become a nuisance. What would have happened if we had a testing technique where, we just needed to prick our finger or swab our nose, put the sample on a chip and in matter of minutes it showed us our health status, I just wonder!
To give you all good news, this is where we are heading right now and this is exactly how we remove that sword from over our heads.
Multiple biosensor companies have treated this pandemic as a blessing in disguise and directed all their resources towards inventing those sensors which can monitor patient’s recovery and above all, detect the presence of virus, antibodies and antigen at a quicker pace.
To go on further, let me just set some definitions straight.
What are Biosensors?
Biosensors, as all the other sensors, are analytical devices that are used to detect the presence of something. Biosensors detect the presence of a biological compound, also referred as biological analyte, a biological structure or a microorganism in a living being. It accomplishes this task by converting a biological response from organisms into quantifiable and processable signals.
Why so Important during pandemic?
This pandemic raged on due to the non-availability of vaccine and cure for it. And the only treatment was self-isolation, proper nutrition, rest and medicines for the symptoms. This made detecting the infection quickly a sine qua nonfor stopping the spread of virus. Therefore, testing quickly with good efficiency was the need of the hour. This makes biosensors extremely important, as they have the potential to detect the presence of virus, antibodies or antigen in a small amount of time with great efficiency.
Market Insights You were Waiting for!
Pandemic affected a lot many markets due to the restrictions placed on global movement of people and freights, and biosensors market was not left out of it. However, as the need for testing and monitoring methods shot up and the restrictions are now being lifted, everything is coming back to normal. In fact, there are lot many new opportunities that found its ways to the market as well. To give you an estimate of the growth market is eyeing, it is expected to grow at a CAGR 7.9% and reach USD 41.8 billion by 2028.
Table below summarizes the state of pandemic impact and post-pandemic outlook in an apt way.
Pandemic Impact
Post-Pandemic Outlook
Pandemic affected the production of the sensors, which led to the demand-supply gap. The situation was aggravated due to the logistical issues faced all over the world on account of the lockdown restrictions.
With the lifting of lockdown restrictions in multiple countries and initiation of manufacturing processes, the demand-supply gap has been observed to be decreasing and market is steadily picking up pace as time passes.
COVID-19 has generated new market opportunities for the biosensors, as there is a high demand for innovative biosensors that can be used in monitoring the health status of the patients.
Biosensors have proved to be a strong dependable rock, when it comes to the detection and monitoring diabetes. Similarly, they are also being looked at for effectiveness in COVID-19 testing and monitoring.
In May 2020, Philips launched the Biosensor BX100 to assist in themonitoring of COVID-19 patients across hospitals. This wireless, wearable biosensor device is specifically designed to detect early deterioration in the affected patients.
Rogue Valley Microdevices is a wafer foundry that specializes in manufacturing microelectromechanical systems (MEMS) and sensors, and it is working with several startups scrambling to produce biosensors for coronavirus testing. Two of those companies—Cardea Bio and Hememics—are talking publicly about their work.
COVID-19 Impact on Biosensors market – A Big Boon
In Conclusion
Yes, similar to every market that suffered due to production and manufacturing halt in addition to logistical issues, biosensors suffered too. However, pandemic also brought slew of opportunities for the market, which are being capitalized on by the major market players, eyeing that exponential growth in the coming years.
The second wave of coronavirus turns out deadly all across the world in 2021 than the first in 2020. Although, the vaccination drives are being conducted throughout the world adhering to the guidelines by WHO, the transmission of virus variants is adding more challenge. The cases of cardiac arrests have been mounting up in the elder patients with a high mortality rate driven by sudden cardiac arrests is one of the major concern associated with COVID infection.
An estimated 3.5 lac sudden cardiac arrest cases occur in the U.S. The research led by Penn revealed that there was decreased in stability for survival of cardiac patients during the pandemic. Mainly, this occurred due to the lack of CPR and fear of viral transmission. However, for infected patients, doctors recommend hands-only CPR (under safe conditions) which is a safe and effective way to help them during cardiac arrests. Even though there is a low risk of transmission.
Simply put, the job of cardiac rhythm management device is to restore normal rhythm/heart functioning in cardiac patients. Cardiac rhythm management devices perform many functions such as bradycardia pacing, defibrillation, pacing for tachyarrhythmias and so on. Any of these implanted device (under supervision of physician) enables the patients to lead normal and active lives. Future projections for developing a leadless yet customized design will be highly innovative. Thus, we can say that the focus will shift from transvenous lead to leadless design in the coming years.
COVID-19 Impact
Post-COVID Outlook
The COVID-19 impact has had a severe impact over cardiology, electrophysiology, and cardiac rhythm management device systems.
The cardiac rhythm management devices market is likely to witness some upcoming trends. Medical companies are proactively providing essential supplies despite the existing challenges.
The quality care in patients is likely to get altered amid the line of procedure for COVID affected patients.
Abbott Laboratories have partnered with support communities to fight against COVID. By collaborating with the communities, they aim to provide access to medicines, diagnostics, nutrition without any disruption
There was sudden spike in the cardiovascular cases affected by coronavirus resulting in the growing need for HRCT, electrocardiogram, and other diagnostic tests.
Home monitoring will gain traction as consumers are adopting SMART wearable gadgets following RPM (Remote Patient Monitoring) techniques for patients.
Briefing the impact COVID-19 has made on the cardiac rhythm management devices market
Summing up:
As we move forward in 2021 with vaccines against COVID-19, it is likely that we might witness a decline trend in fresh cases all across the world. Hopefully, this will reduce the burden on healthcare systems. On the other hand, patients in a post-COVID phase should still continue with health precautions as advised by their doctors and physicians. This is likely to encourage the use of pacemakers, defibrillators, and implantable devices to monitor heart health in the coming time as remote monitoring and homecare for cardiac patients will be a major norm.
COVID-19 has impacted every sector of the world’s economy including healthcare. Along with frontline workers, healthcare workers have also been majorly exposed to the maximum risk of the deadly virus. Due to the COVID-19, elective surgeries have been canceled by the majority of the hospitals to reduce the direct contact of surgeons with the patients. As a result, both patients and hospitals are bearing a heavy loss. And there comes the robotic surgery in rescue wherein there is no fear of social contacting with the patients by the doctors. In this article, we are focusing on FAQs on robotic surgery along with how this market has been affected by COVID-19.
Content
Section -I
What is the history of robotic surgery?
Is robotic surgery better than traditional surgery?
What are the risks of robotic surgery?
What is MAKOplasty?
What is a CMR robot?
Section -II
What is the impact of COVID-19 on robotic surgery?
FREQUENTLY ASKED QUESTIONS
What is the history of robotic surgery?
The actual idea behind the robotic surgery was to conduct the surgery remotely without getting near to the patients. Here are the further details.
The first surgical robots were the Arthobot which were capable of positioning the patients during orthopedic surgery by using voice commands. They were made and used for the first time in Vancouver, BC, Canada in 1983.
After few years, on 11th April 1985, Unimation Puma 200, an industrial robot, was used by Long Beach Memorial Medical Center in California used to orient a needle for brain biopsy.
In 1996, the Automated Endoscopic System for Optimal Positioning (AESOP) introduced a complete robotic surgical system, named ZEUS, with 7 degrees of freedom, motion scaling, and tremor elimination. ZEUS attempted its first surgery (laparoscopic cholecystectomy) in France while the surgeons were located in New York.
Another breakthrough was the Da Vinci robotic surgery/Da Vinci surgical system which was approved by the FDA in 2000. It was capable of doing minimally invasive surgery where the surgeons controlled the process from a console.
Today, there have been many other robots developed that can assist in surgery and are commercially available for various surgical procedures across different domains.
Is robotic surgery better than traditional surgery?
Robotic surgery has various advantages and that’s why it is better than traditional surgery. Have a look!
With less tissue damage while attempting robotic surgery, patients recover faster.
As incisions are very small, hence, patients feel less pain during the robotic surgery, and chances of getting infection after the surgery also reduce.
Doctors get access to real images of the operating area as a high-resolution camera is used during robotic surgery. This helps the doctor(s) in taking better decisions.
As there is very minimal loss of blood during robotic surgery, hence, blood transfusion also gets reduced.
With the help of robots, complex surgeries can be done which is difficult to do with traditional surgeries.
The patient’s stay–time in the hospital also gets reduced in the case of robotic surgery.
Last but not the least, the precision achieved during robotic surgery is very high compared to traditional surgery.
What are the risks of robotic surgery?
Robotic surgery is safe, but not 100%. Having said that, the percentage of risk involved in robotic surgery is very low compared to traditional surgery.
There are minimal chances of getting a small infection after the surgery.
Alike traditional surgery, there are chances that after the robotic surgery, bleeding can happen which can result in breathing problems as well.
What is MAKOplasty?
Makoplasty is a partial knee resurfacing procedure done with the help of a robotic arm. The robotic arm helps the patients by relieving them from pain caused by joint degeneration due to osteoarthritis. During Makoplasty, the surgeon focus on resurfacing the knee by selectively targeting the part of the knee damaged by osteoarthritis. It is beneficial as during the whole process the healthy bone and ligaments remain untouched.
What is a CMR robot?
CMR Surgical is a company based in Impington which produces a robotic surgery system known as Versius. The company got established in 2014. The Versius is famous because it is the first-ever robot that performs Minimal Access Surgery (MAS/laparoscopic/keyhole surgery). MAS is basically the abdominal operation done with small incisions of 1 cm – 1.5 cm in length. It brings lots of advantages such as reduced stay in the hospital, reduced rate of infection and scarring, reduced after-surgery pain, and increased recovery speed.
IMPACT OF COVID-19 ON ROBOTIC SURGERY
The following table will give you a gist of how robotic surgery has been impacted with the COVID-19. Have a look!
S. No.
Basis of Comparision
Pre-COVID
Impact of COVID
1.
Demand
Pre-COVID the robotic surgery was less opted by the patients compared to post-covid.
To follow the social distancing, robotic surgery has come as a boon. Hospitals are seeing an increased demand for robotic surgery due to the various benefits it offers.
2.
Telemedicine
Pre-COVID, assistance through telemedicine was negligible.
Post-COVID, telemedicine has proved to be beneficial as the non-emergent operations were put on hold to curb the spread of COVID-19. With the help of telemedicine, non-emergency patients are being evaluated, assessed, and counseled remotely. Also, when the non-emergent surgeries will start, these patients would have already done with their pre-operative requirements.
3.
Market Size
Surgical robots market was growing.
Surgical robots market declined by 7.7% from 2019 to 2020 majorly because of the closure of elective surgeries.
Capnography is a term which most of us have not heard in our lifetime, but, in the medical community, this is a very common term. As I encountered with this term a few days back, I tried researching on it all the basic questions like what Capnography is, what it is used for, what are its types, etc. but sadly, I couldn’t find all the information at just one-two websites. I had to struggle hard to find all the information. That’s why I thought of writing this article in a FAQ format so that you get all the best quality information in the least amount of time.
The focal point of this article is to talk about the impact of COVID-19 on capnography monitoring devices, however, I am starting with the basic questions. As you understand the basics of it, it will be really helpful to you to understand the “impact of COVID-19” section clearly. So here we go ladies and gentlemen.
Section – I
We will be covering the following FAQs. Click to directly jump to the specific question.
What are Capnography devices?
What is the difference between Capnometry, Capnography, Capnometer, and Capnograph?
What are the three types of Capnography?
How do we measure EtCO2?
What is the normal range of EtCO2?
What causes high EtCO2?
Section – II
Impact of COVID-19 on Capnography Devices
SECTION – I
FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions
What are Capnography devices?
That’s the first question even I had in my mind but before I dive straight to the main course, let’s have starters first. Ahm Ahm, I meant let’s look back at the history of Capnography first. *wink*
Capnometry was first used in World War II to monitor the internal environment. Its application in healthcare was first seen in 1950 to measure the amount of carbon dioxide (CO2) released during anesthesia but it was in the early 1980s when it was actually practiced by doctors. Slowly, when the devices started getting smaller in size, Capnography officially marked its presence in the field of anesthesia.
So, by now you would have guessed what’s in the “main course”. Isn’t it? Smart people For better clarity, please refer to the below definition.
“Capnography monitor or device is something used mostly in hospitals to keep a check on the CO2 level in the respiratory gases (or the air we exhale) of the patients.”
What is the difference between Capnometry, Capnography, Capnometer, and Capnograph?
Often people get confused with these three terms which are usually used interchangeably. But after reading the definition, you will understand how these three terms differ from each other.
Capnometry: Capnometry is the measurement and display of carbon dioxide in numeric form only, i.e., end-tidal and inspired CO2.
Capnography: Capnography is the exhaustive measurement and display of carbon dioxide in not the only numeric format but also in the form of Capnogram (real-time CO2 waveform).
Capnometer: The device which is responsible for measuring and displaying the end-tidal and inspired CO2.
Capnograph: The device which is responsible for measuring and displaying the CO2 in a waveform.
What are the three types of Capnography?
Three types of Capnograph are: Sidestream, Mainstream, and Microstream. Let’s understand each one in brief.
Sidestream: Sidestream monitor is placed away from the breathing passage of the patient. Therefore, it relies on the other monitor connected to the patient’s breathing passage by a tube. Through the ventilator circuit, the gas samples are aspirated from the exhaled gas. Sidestream monitors are specifically used in non-intubated patients.
Mainstream: Mainstream monitor is used in the case of intubated patients wherein it is directly placed at the breathing passage of the patient to measure the CO2. Hence, within a short period, the doctors get the required amount of sample gas which is smaller compared to sidestream monitoring. However, the disadvantage mainstream monitor offer is that it cannot be used in non-intubated patients and it also adds weight to the airway.
Microstream: Microstream is the new type of capnograph that uses molecular correlation spectrography for accurate results. The Microstream monitors also give rapid results and can be used in both intubated and non-intubated patients.
How do we measure EtCO2?
EtCO2 stands for End Tidal CO2. It is the level of CO2 that has been released at the end of an exhaled breath. To measure the EtCO2, you need to consider three things: The EtCO2 value, the respiratory rate (RR), and the waveform shape. The numerical data is easily understandable, however, understanding the waveform shape requires special knowledge, hence, please focus on the information below:
There are 4 phases while we measure the EtCO2. Have a look!
Phase 1: Exhalation will start and the concentration of the CO2 will be zero.
Phase 2: The CO2 will increase gradually as the alveolar gas exits the breathing passage of the patient.
Phase 3: In the 3rd phase, the CO2 concentration will be comparatively constant and by the end of phase 3rd, the CO2 concentration will be maximum.
Phase 4: Inhalation will start and CO2 will reduce to zero again.
What is the normal range of EtCO2?
The normal EtCO2 has the following features:
The waveform always starts with zero and ends at zero after the completion of the process.
The maximum CO2 is reached with every breath that corresponds to the EtCO2.
The width of the waveform depends on the expiratory time.
The amplitude of the waveform depends on the concentration of the EtCO2.
The normal range of EtCO2 is 5%-6%CO2 which is equivalent to 35-45 mmHg or 4.0-5.7 kPa.
Waveform should be rectangular in shape with rounded corners.
For adults who are on ventilation, the rate should be 10-12 bpm and without ventilation, the rate should be 12-20 bpm. Children should be ventilated and the rate should be 15-30 bpm and in the case of infants, it should be 25-50 bpm.
What causes high EtCO2?
The end tidal CO2 can be caused by many reasons. Majorly there are 4 reasons which are enlisted below:
Rapid increase in body temperature (malignant hyperthermia)
Decrease in metabolic rate
Decrease in respiratory rate (hypoventilation)
Decrease in tidal volume (hypoventilation)
SECTION – II
IMPACT OF COVID-19 ON CAPNOGRAPHY DEVICES
Impact of COVID-19 on CapnographyDevices
The following table will help you understand how the capnography market was behaving pre-COVID and how it is behaving post-COVID. Have a look!
S.No.
Scope
Pre-COVID
Post-COVID
1.
Resource Allocation
The Anesthesiologists and certified registered CRNAs (nurse anesthetists) were earlier looking after the Operating Room (OR) patients as surgeries used to happen in that room.
Post-COVID, the Anesthesiologists and certified registered CRNAs have been relocated to the ICUs, which have now become COVID-19 units, as surgeries have got canceled due to COVID and their expertise is beneficial for the COVID patient’s recovery.
2.
Remote monitoring of EtCO2
Pre-COVID, doctors were measuring the EtCO2 in real-time without maintaining any social distancing or working remotely.
To follow the social distancing and supporting the conservation of the PPE, capnography devices are connected to a remote monitoring platform, such as Vital Sync remote monitoring technology, to measure the CO2.
3.
Scope
The scope of capnography was limited to monitoring ventilation.
The scope has expanded dramatically. Now, apart from ventilation, capnography has been used to access the airway patency and placement, assessment of intervention and treatment effectiveness, assisting in the identification of coagulation problems such as emboli, PE, DVT, etc.
4.
Filtration of the capnography sampling line
Not required
As the size of the COVID virus is very small compared to the size of aerosol (through which COVID enters the body) droplets, the Anesthesia Patient Safety Foundation (APSF) has created COVID-19 specific resources for filtering the capnography sampling line.
Showing the impact of COVID-19 on Capnography
Conclusion
Capnography is the device that is used by healthcare facilities to monitor the EtCO2. There are three types of capnography: Sidestream, Mainstream, and the latest Microstream. There is a total of 4 phases of measuring the EtCO2 wherein the normal range features zero waveforms at the start and returning back to zero at the end.
The causes of high end tidal CO2 are mainly an increase in the body temperature, and a decrease in the metabolic rate, respiratory rate, and tidal volume. Finally, we have discussed the impact of COVID-19 on capnography devices wherein we found some interesting facts. If you have mistakenly jumped at the conclusion section, please do check out the table to get insights into the impact of COVID-19 on capnography devices.
Nothing compares to the simple pleasure of riding a bike. – JFK
To some it is a means of commuting, to others it is a way to clear their head. To some it helps save environment, to others it helps them keep healthy. And then for some it is a sport, but for me, it is my lifestyle. Cycling has been with me, since my father bought me one when I was just 8 years old. That was the best day of my entire year. I showed it off to my friends, rode it with them to playgrounds, school and then, to college. Some people might say its unfortunate to ride a bike to college, to them I say, To each his own magic!
I used to love every second of it. And still do.
I am sure there are plenty of others like me, just as crazy about cycling as I am. And I am counting on some of them being, a market researcher, interested in the ups & downs of the bicycle market. This infographic blog post is for them. The infographic given below explains about the bicycle market growth drivers in a fun way for you to grasp and take something home with you. Sneak a peek!
To those, who reached till here, I would like to inform you that bicycle market size is anticipated to reach USD 92.49 billion by 2028, registering a CAGR of 7.0% till 2028, according to a new report by Grand View Research, Inc. In addition to this, some other market stats are provided below, for your better understanding.
Some cool market facts to understand –
The global market is growing significantly as bike-sharing companies, particularly in Europe and Asia, are investing aggressively in expanding their operations
The mountain bicycle segment is anticipated to expand at a CAGR exceeding 7% by 2028. Rising popularity in line with the increasing media coverage for mountain bicycle racing events and the establishment of new mountain biking circuits are expected to drive the growth
Apart from being easy to use, electric bicycles can potentially shorten the journey time. Moreover, advances in battery technology have resulted in the advent of lighter rechargeable batteries that can support longer journeys. These factors are attributed to the growth of the electric bicycle segment
The men segment is expected to expand significantly at a CAGR of over 7.2% by 2028 as men would continue to outnumber women and kids in terms of opting for a bicycle commute. The number of men opting for bicycle commutation was higher than that of women and kids in 2019
Asia Pacific was the dominant regional market in 2020 with a revenue share exceeding 34%. Governments in Asian nations, particularly Japan, China, and Singapore, among others, are investing aggressively in establishing the infrastructure necessary to encourage and support bicycle commutation
Leading market incumbents are Accell Group; Dorel Industries Inc.; Giant Bicycles; Merida Industry Co., Ltd.; and Trek Bicycle Corporation. They dominated the market in 2020 leveraging a continuous emphasis on expanding their market share through mergers and acquisitions
If you want to know more about the growing market of bicycles, please visit Grand View Research, Inc., and ask for a free sample of the report.
